Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234

Autor: Chieko Michikawa, DDS, PhD, Pedro A. Torres-Saavedra, PhD, Natalie L. Silver, MD, MS, Paul M. Harari, MD, Merrill S. Kies, MD, David I. Rosenthal, MD, Quynh-Thu Le, MD, Richard C. Jordan, DDS, PhD, Dzifa Y. Duose, PhD, Saradhi Mallampati, DVM, PhD, Sanchit Trivedi, MS, Rajyalakshmi Luthra, PhD, Ignacio I. Wistuba, MD, Abdullah A. Osman, PhD, Olivier Lichtarge, MD, PhD, Robert L. Foote, MD, Upendra Parvathaneni, MBBS, D. Neil Hayes, MD, MPH, Curtis R. Pickering, PhD, Jeffrey N. Myers, MD, PhD

Publikováno v: Advances in Radiation Oncology, Vol 7, Iss 6, Pp 100989- (2022)

Purpose: An evolutionary action scoring algorithm (EAp53) based on phylogenetic sequence variations stratifies patients with head and neck squamous cell carcinoma (HNSCC) bearing TP53 missense mutations as high-risk, associated with poor outcomes, or

Externí odkaz: https://doaj.org/article/af4a399b5e144a18b46cb1524d746ef0

Decreased brain levels of vitamin B12 in aging, autism and schizophrenia

Autor: Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do KQ, Deth RC

Publikováno v: PloS One

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=snsf_p3_pubs::68803009814fa7c8101ffda6b269bd19
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723262/pdf/pone.0146797.pdf

Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women.

Autor: Trivedi MS; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, 161 Fort Washington Avenue HIP 10, New York, NY, 10032, USA. mst2134@cumc.columbia.edu., Manley H; College of Law, DePaul University, Chicago, IL, USA., Yi H; Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY, USA., Silverman T; Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA., Chung WK; Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA., Appelbaum PS; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA., Starck R; Institute for Applied Research and Community Collaboration (ARCC), Spring Valley, NY, USA., Schecter I; Institute for Applied Research and Community Collaboration (ARCC), Spring Valley, NY, USA.; Achieve Behavioral Health, Monsey, NY, USA., Kukafka R; Department of Biomedical Informatics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA., Crew KD; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, 161 Fort Washington Avenue HIP 10, New York, NY, 10032, USA.

Publikováno v: Familial cancer [Fam Cancer] 2024 Nov; Vol. 23 (4), pp. 491-498. Date of Electronic Publication: 2024 Apr 12.

Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.

Autor: Shatsky RA; University of California San Diego, San Diego, CA, USA., Trivedi MS; Columbia University, New York, NY, USA., Yau C; University of California San Francisco, San Francisco, CA, USA., Nanda R; University of Chicago, Chicago, IL, USA., Rugo HS; University of California San Francisco, San Francisco, CA, USA., Davidian M; North Carolina State University, Raleigh, NC, USA., Tsiatis B; North Carolina State University, Raleigh, NC, USA., Wallace AM; University of California San Diego, San Diego, CA, USA., Chien AJ; University of California San Francisco, San Francisco, CA, USA., Stringer-Reasor E; University of Alabama at Birmingham, Birmingham, AL, USA., Boughey JC; The Mayo Clinic, Rochester, MN, USA., Omene C; Cooperman Barnabas Medical Center, New Brunswick, NJ, USA.; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Rozenblit M; Yale University, New Haven, CT, USA., Kalinsky K; Emory University, Atlanta, GA, USA., Elias AD; University of Colorado, Denver, CO, USA., Vaklavas C; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Beckwith H; University of Minnesota, Minneapolis, MN, USA., Williams N; The Ohio State University, Columbus, OH, USA., Arora M; University of California Davis, Davis, CA, USA., Nangia C; HOAG Family Cancer Institute, Newport Beach, CA, USA., Roussos Torres ET; University of Southern California, Los Angeles, CA, USA., Thomas B; Sparrow Health System, Lansing, MI, USA., Albain KS; Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA., Clark AS; University of Pennsylvania, Philadelphia, PA, USA., Falkson C; University of Rochester Medical Center, Rochester, NY, USA., Hershman DL; Columbia University, New York, NY, USA., Isaacs C; Lombardi Comprehensive Cancer Center Georgetown University, Washington, DC, USA., Thomas A; Wake Forest University, Winston-Salem, NC, USA., Tseng J; City of Hope Orange County Lennar Foundation Cancer Center, Irvine, CA, USA., Sanford A; Sanford Health, Sioux Falls, SD, USA., Yeung K; University of California San Diego, San Diego, CA, USA., Boles S; University of California San Diego, San Diego, CA, USA., Chen YY; University of California San Francisco, San Francisco, CA, USA., Huppert L; University of California San Francisco, San Francisco, CA, USA., Jahan N; University of Alabama at Birmingham, Birmingham, AL, USA., Parker C; University of Alabama at Birmingham, Birmingham, AL, USA., Giridhar K; The Mayo Clinic, Rochester, MN, USA., Howard FM; University of Chicago, Chicago, IL, USA., Blackwood MM; Cooperman Barnabas Medical Center, New Brunswick, NJ, USA., Sanft T; Yale University, New Haven, CT, USA., Li W; University of California San Francisco, San Francisco, CA, USA., Onishi N; University of California San Francisco, San Francisco, CA, USA., Asare AL; University of California San Francisco, San Francisco, CA, USA.; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Beineke P; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Norwood P; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Brown-Swigart L; University of California San Francisco, San Francisco, CA, USA., Hirst GL; University of California San Francisco, San Francisco, CA, USA., Matthews JB; University of California San Francisco, San Francisco, CA, USA., Moore B; Wake Forest University, Winston-Salem, NC, USA., Symmans WF; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Price E; University of California San Francisco, San Francisco, CA, USA., Heditsian D; University of California San Francisco, San Francisco, CA, USA., LeStage B; University of California San Francisco, San Francisco, CA, USA., Perlmutter J; The Gemini Group, Ann Arbor, MI, USA., Pohlmann P; University of Texas MD Anderson Cancer Center, Houston, TX, USA., DeMichele A; University of Pennsylvania, Philadelphia, PA, USA., Yee D; University of Minnesota, Minneapolis, MN, USA., van 't Veer LJ; University of California San Francisco, San Francisco, CA, USA., Hylton NM; University of California San Francisco, San Francisco, CA, USA., Esserman LJ; University of California San Francisco, San Francisco, CA, USA. laura.esserman@ucsf.edu.

Publikováno v: Nature medicine [Nat Med] 2024 Sep 14. Date of Electronic Publication: 2024 Sep 14.

Metformin-induced oxidative stress inhibits LNCaP prostate cancer cell survival.

Autor: Dixon S; Department of Pharmaceutical Sciences, Barry and Judy Silverman's College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL, 33328, USA. sd1686@nova.edu., Tran A; Halmos College of Natural Sciences and Oceanography, Nova Southeastern University, Ft. Lauderdale, Florida, 33328, USA., Schrier MS; Department of Pharmaceutical Sciences, Barry and Judy Silverman's College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL, 33328, USA., Dong J; Department of Pharmaceutical Sciences, Barry and Judy Silverman's College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL, 33328, USA., Deth RC; Department of Pharmaceutical Sciences, Barry and Judy Silverman's College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL, 33328, USA., Castejon A; Department of Pharmaceutical Sciences, Barry and Judy Silverman's College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL, 33328, USA., Trivedi MS; Department of Pharmaceutical Sciences, Barry and Judy Silverman's College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL, 33328, USA.

Publikováno v: Molecular biology reports [Mol Biol Rep] 2024 Jun 12; Vol. 51 (1), pp. 729. Date of Electronic Publication: 2024 Jun 12.